Overview

Thyroid Associated Orbitopathy Treatment by Methotrexate Against Triamcinolone Periocular Injections

Status:
Active, not recruiting

Trial end date:
2022-07-15

Target enrollment:

Participant gender:

Summary

The study objective is to investigate the efficacy and safety of periocular injections of methotrexate in management of patients with active moderate to severe thyroid associated orbitopathy in comparison to periocular injections of triamcinolone acetonide.

Phase:

Phase 2

Details

Lead Sponsor:

Cairo University

Treatments:

Methotrexate
Triamcinolone
Triamcinolone Acetonide
Triamcinolone diacetate
Triamcinolone hexacetonide